Invesco Biotechnology & Genome ETF
PBE
PBE
69 hedge funds and large institutions have $52.3M invested in Invesco Biotechnology & Genome ETF in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
13% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 16
Holders
69
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.12M | |
| 2 | +$400K | |
| 3 | +$318K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$232K |
| 5 |
BTS
BB&T Securities
Richmond,
Virginia
|
+$226K |
Top Sellers
| 1 | -$1.72M | |
| 2 | -$547K | |
| 3 | -$525K | |
| 4 |
Goldman Sachs
New York
|
-$256K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$226K |